Page results
-
The aim of the Enhanced Recovery Programme (ERP) is to get you back to full health as quickly as possible after your operation. Research indicates that after surgery, the earlier you get out of bed,…
-
This leaflet explains the options for sensitive handling of pregnancy tissue.
-
Introduction Fatigue is a common and invisible symptom that is not always obvious to others such as partners, family members, friends or colleagues. As a result others may not understand the…
-
Our gynaecology diagnostic and treatment unit encompasses the following services: Early pregnancy clinic General gynaecology clinic Suspected gynaecological…
-
This service offers care to young people with a range of conditions from period problems through to rare and complex congenital abnormalities of the genital tract. We offer a multidisciplinary…
-
COVID-19 information for patients and visitors With rates of COVID-19 on the rise again, we are providing the following information to patients and visitors. Patients Please continue to…
-
“No one is invulnerable” – stark messages from patients and staff about the realities of coronavirus
The enormous pressure our staff are under was the focus of a powerful BBC News report about the surge in Covid-19 cases broadcast on Wednesday 6 January.
-
This page will give you an overview of intravesical thermo-chemotherapy, how it is given and side effects it may cause.
File results
-
FOI/2022/0546 - Metastatic Cholangiocarcinoma (CCA) or Acute myeloid leukaemia
-
FOI/2022/0548 - Biologic and biosimilar products within Rheumatology
-
FOI/2022/0549 - SACT (systemic anti-cancer therapy) /cervical cancer treatments
-
FOI/2022/0550 - Patients that have been treated for glioblastoma brain cancer
-
FOI/2022/0553 - Patients tested for non-small cell lung cancer biomarkers
-
FOI/2022/0561 - Regulation (EU) 2016/425 Declarations of Conformity for all type IIR surgical masks provided as PPE to staff
-
FOI/2022/0571 - Treatment for biologic medicines in Dermatology
-
FOI/2022/0572 - Treatments for Hidradenitis Suppurativa and Psoriasis
-
FOI/2022/0573 - Use of WhatsApp by or within the Trust
-
FOI/2022/0513 - Myelofibrosis treatment